Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 22;20(1):e0316175.
doi: 10.1371/journal.pone.0316175. eCollection 2025.

Impact of high body mass index on hepatocellular carcinoma risk in chronic liver disease: A population-based prospective cohort study

Affiliations

Impact of high body mass index on hepatocellular carcinoma risk in chronic liver disease: A population-based prospective cohort study

Moonho Kim et al. PLoS One. .

Abstract

Background and aims: We investigated associations between body mass index (BMI) and hepatocellular carcinoma (HCC) in patients with hepatitis B (HBV) C (HCV) virus infection, alcoholic liver disease (ALD), non-alcoholic fatty liver disease (NAFLD), and liver cirrhosis (LC).

Methods: We followed 350,608 Korean patients with liver disease who underwent routine health examinations from 2003-2006 until December 2018 via national hospital discharge records. Multivariable adjusted hazard ratios (HRs) per 5-kg/m2 BMI increase (BMI ≥25 kg/m2) for HCC risk were calculated using Cox models. HCC developed in 17,752 patients.

Results: The HRs (95% CI) were 1.17 (1.06-1.28), 1.08 (0.87-1.34), 1.34 (1.14-1.58), 1.51 (1.17-1.94), and 1.11 (1.00-1.23) for HBV, HCV, ALD, NAFLD, and LC, respectively. The HRs for HBV were 1.45 (1.23-1.70) and 1.06 (0.95-1.19) in women and men, respectively; the corresponding HRs for LC were 1.27 (1.07-1.50) and 1.02 (0.90-1.16), respectively. In patients <65 years old with HBV, HCV, and NAFLD, the HRs were 1.17 (1.07-1.29), 1.33 (1.03-1.73), and 1.20 (0.87-1.64), respectively; the corresponding HRs were 1.05 (0.70-1.59), 0.74 (0.50-1.10), and 2.40 (1.62-3.54), respectively, in patients ≥65 years old. A BMI of 27.5-29.9 kg/m2 showed significantly higher HCC risks in patients with HBV, ALD, NAFLD, and LC.

Conclusions: Higher BMIs were associated with increased HCC risks in patients with HBV, ALD, NAFLD, and LC. Overweight status increased HCC risk. Women with HBV and LC had stronger BMI-HCC associations than men. The effect of high BMI was stronger in older patients with NAFLD and younger patients with viral hepatitis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Flow diagram of the study cohort.
Fig 2
Fig 2. Hepatocellular carcinoma risk according to liver disease, for each 5-kg/m2 BMI increase in patients with BMI ≥25 kg/m2.
HBV, hepatitis B virus; HCV, hepatitis C virus; ALD, alcoholic liver disease; NAFLD, nonalcoholic fatty liver disease; LC, liver cirrhosis; BMI, body mass index.
Fig 3
Fig 3. Cox regression analysis of hepatocellular carcinoma risk according to liver disease, for each 5-kg/m2 BMI increase in patients with BMI ≥25 kg/m2.
HBV, hepatitis B virus; HCV, hepatitis C virus; ALD, alcoholic liver disease; NAFLD, nonalcoholic fatty liver disease; LC, liver cirrhosis; BMI, body mass index.

Similar articles

References

    1. N’Kontchou G, Paries J, Htar MTT, Ganne-Carrie N, Costentin L, Grando-Lemaire V, et al.. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis. Clin Gastroenterol Hepatol. 2006;4: 1062–1068. doi: 10.1016/j.cgh.2006.05.013 - DOI - PubMed
    1. Ioannou GN, Splan MF, Weiss NS, McDonald GB, Beretta L, Lee SP, et al.. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2007;5: 938–945, 945.e1-4. doi: 10.1016/j.cgh.2007.02.039 - DOI - PubMed
    1. Yu MW, Shih WL, Lin CL, Liu CJ, Jian JW, Tsai KS, et al.. Body-mass index and progression of hepatitis B: a population-based cohort study in men. J Clin Oncol. 2008;26: 5576–5582. doi: 10.1200/JCO.2008.16.1075 - DOI - PubMed
    1. Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, et al.. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology. 2008;135: 111–121. doi: 10.1053/j.gastro.2008.03.073 - DOI - PubMed
    1. Nair S, Mason A, Eason J, Loss G, Perrillo RP. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology. 2002;36: 150–155. doi: 10.1053/jhep.2002.33713 - DOI - PubMed

MeSH terms